PK and PD of Albuterol Spiromax® and ProAir® Hydrofluoroalkane in Pediatric Patients With Asthma

Study Title

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Teva Identifier

ABS-AS-102

ClinicalTrials.gov Identifier

NCT01844401

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

4 Years to 11 Years

Trial Duration

04/01/2013 - 10/01/2013

Phase

Phase 1

Study Type

Interventional